Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
251 - 260 of 892 results
  • Abstract
    Prenatal tetrahydrocannabinol exposure causes strong reductions in omega-3 fatty acid levels in mesocorticolimbic brain circuits: Implications for increased neuropsychiatric vulnerability
    Acute or chronic exposure to tetrahydrocannabinol (THC), the primary psychotropic component of cannabis, is known to induce schizophrenia-like symptoms in humans and other animals. The developing brain is particularly sensitive to the effects of THC. Wh...
    Oct 23, 2019
  • Abstract
    The effects of alcohol and THC co-use during adolescence on synaptic plasticity in the medial prefrontal cortex of Long Evans rats
    Adolescent exposure to alcohol or delta-9-tetrahydrocannabinol (THC), which is the main psychoactive component in cannabis, has been associated with structural and functional changes in the brain of adult humans and laboratory animals. Considerably less...
    Nov 10, 2021
  • Abstract
    The synthetic cannabinoid agonist win 55, 212-2 injected in young animals blocks the sleep rebound after total sleep deprivation in adulthood
    More than 500 molecules have been identified as components of Cannabis sativa, of which the most studied is Δ9-tetrahydrocannabinol (Δ9-THC). Several studies have indicated that Δ9-THC exerts diverse biological effects, ranging from fragmentation of DNA...
    Oct 20, 2019
  • Abstract
    Chronic treatment with delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens and medial prefrontal cortex of rats.
    The potential of repeated exposure to delta-9-tetrahydrocannabinol (THC) to produce long lasting changes in synaptic connections in a manner similar to other drugs of abuse was evaluated in Sprague-Dawley rats. For 14 days, rats received two intraperitoneal injections per day (8 hr apart) of vehicle, a low dose of THC (0.5 mg/kg) or escalating doses of THC (0.5 – 4.0 mg/kg). Thirty days later, they were evaluated for sensitized locomotor activity (during the night cycle) for 60 min on each of three trials. Using a within-groups design, rats were tested following an injection of vehicle, 0.5 mg/kg THC or 2.0 mg/kg. The rats showed no evidence of sensitized locomotor activity in any group. On Day 33, their brains were removed and then processed for Golgi-Cox staining. Prior exposure to THC (both the low dose and the escalating doses) increased the length of the dendrites as well as the number of dendritic branches in the shell of the nucleus accumbens and in the medial prefrontal cortex. There were no signif...
    Oct 26, 2004
  • Abstract
    What is the 'motivational' mechanism for the marijuana munchies? The effects of intra-accumbens anandamide on hedonic taste reactions to sucrose.
    Increased eating is a common effect of systemically-administered cannabinoid drugs in both humans and rats. Microinjections of these drugs into the nucleus accumbens shell (NAc) and other brain areas can also increase feeding in rats. The psychological mechanism of these effects is as yet unknown, however. In particular, it is unknown whether cannabinoids actually increase palatability of tastes (‘liking’), beyond elevating food intake. The taste reactivity test is a useful way to assess changes in hedonic impact of taste palatability in rats. In these experiments, we tested whether intra-nucleus accumbens microinjections of anandamide altered positive hedonic reactions (e.g. tongue protrusions, paw licking) elicited by oral infusions of sucrose solution. We then compared these hedonic effects to effects of the same microinjections on food intake. These results provide insight into the involvement of NAc cannabinoid receptors in food ‘liking’ vs. ‘wanting.’.
    Oct 25, 2004
  • Abstract
    Anticonvulsant effect of cannabidiol in female rats during two phases of estrous cycle on a PTZ-induced convulsive seizure model
    Cannabidiol (CBD) is one of the major cannabinoids present in Cannabis sativa with great therapeutic potential. According to evidence from preclinical and clinical studies, CBD was shown to have anticonvulsive effect and has recently been proposed for t...
    Nov 6, 2018
  • Abstract
    Curcumin (Curc) or its metabolite tetrahydrocurcumin (THC) reduces the production of nitric oxide synthase (iNOS) in mouse brain.
    Curcumin (Curc) and tetrahydrocurcumin (THC) are both phenolic compounds, exerting antioxidant and anti-inflammatory properties that contribute to neuroprotection, for example, in Alzheimer’s Disease (AD) and in chemoprevention. One inflammatory pathway that has been implicated in both diseases is iNOS which catalyzes the production of nitric oxide (NO). Here we examine the bioavailability and anti-inflammatory effects of Curc and THC with different routes of administration: (gavage, GV; intra-muscular, IM; or intra-peritoneal, IP). Mice were injected IP with LPS (lipopolysaccharide, 0.5 µg/g body weight) or vehicle and iNOS production measured in mouse brain. We administered Curc and THC by GV, IP and IM (0.4, 0.4,and 0.2µmoles, respectively) to C57bl mice with or without LPS and collected their plasma and brain. IM-injected Curc and THC resulted in their elevation in plasma and brain by HPLC detection,and significantly reduced CNS iNOS production by Western. Two-step QPCR studies of mouse brain tissue al...
    Oct 24, 2004
  • Abstract
    Prenatal THC exposure permanently disturbs kynurenic acid and glutamate levels and amplifies the responsivity to an acute kynurenine challenge in the rat prefrontal cortex
    Throughout the world, cannabis remains one of the most widely used illicit drugs during pregnancy (Porath-Waller, 2015). The main psychoactive component of marijuana (delta9-tetrahydrocannabinol, THC) passes through the placenta, and its use is correlat...
    Nov 6, 2018
  • Abstract
    NEURONAL ACTIVITY IN THE BASAL GANGLIA SYSTEM DURING FREELY MOVING AND TREADMILL TASKS IN RATS, THE EFFECTS OF Delta-9-THC.
    To estimate the effects of Delta-9-THC on locomotion activities, we used multiple-channel, single unit recording technique to investigate the neuronal activity in the dorsal striatum, the globus pallidus, the subthalamic nucleus and the substantia nigra pars reticulata during freely moving and treadmill locomotion tasks in rats. Sixty-four stainless steel microwires were implanted in those brain areas and neuronal activity were recorded simultaneously with a 64 channel recording device. Six infrared beams were used to measure the locomotion activity in the open field condition. Delta-9-THC pre-treatment (0.05-2.0mg/kg, i.p.) caused a decrease in locomotion activity in a clear dose dependent manner. Delta-9-THC treatment resulted in significant inhibition in the neural activities across all four basal ganglia areas recorded in the freely moving conditions. A treadmill task was employed to test the actions of Delta-9-THC in different behavioral contexts. Each trial consists of 20 seconds walking followed by ...
    Nov 13, 2001
  • Abstract
    Effects of cannabinoids on conditioned and unconditioned aversive behaviour in rats.
    Cannabinoid receptor agonists may produce anxiogenic and anxiolytic effects in rats. Clinical reports suggest that cannabidiol (CBD) attenuates aversive effects of Δ9-tetrahydrocannabinol (Δ9-THC). We investigated the effects of Δ9-THC and CBD on conditioned and unconditioned aversion. Male Lister-Hooded rats (250-300g, n=6-8) received (i.p.)Δ9-THC (1 or 10 mg/kg), CBD (5 or 50 mg/kg) or vehicle (ethanol:cremophor:saline; 1:1:18) 30 min prior to aversive conditioning (10x1s foot shocks, 0.4mA, 1 min intervals). After 24 hrs, duration of contextually-induced freezing was scored. Separate groups of rats received (i.p.) Δ9-THC (1 mg/kg), Δ9-THC (1 mg/kg) + CBD (5 mg/kg), CBD (5 mg/kg) or vehicle 30 min prior to 3 min exposure to ultrasound (20kHz, 85dB). Freezing and explosive hyperlocomotor activity were scored. Drug effects on locomotor activity were assessed separately in activity boxes. Data analysed by one-way ANOVA and Duncan’s multiple range test. Contextually-induced freezing was significantly attenua...
    Nov 12, 2003
  • Previous
  • 24
  • 25
  • 26
  • 27
  • 28
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience